Glioblastoma trials in Spain
10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Where
- Barcelona, Donostia, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 116 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT05765812 · EU 2022-502156-31-00 - Phase 1/2Taking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Barcelona, Logroño, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Valencia
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - No phaseNot yet taking people in SpainAn Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Where
- Barcelona
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT07867886 - Phase 1/2Taking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Pamplona, Sevilla, Valencia
- Age
- Up to 25 years
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - Phase 3Taking peopleLomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Where
- Badalona, L'Hospitalet de Llobregat, Madrid
- Age
- 18 years and over
- People
- 411 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00 - Phase 1/2Taking peopleStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Where
- Boadilla del Monte
- Age
- 3 years and over
- People
- 25
- Run by
- Fundación de investigación HM
See details and how to joinNCT06607692 · EU 2024-512613-40-00 - Phase 2Taking peopleSurgery for Recurrent Glioblastoma
- Where
- Barcelona
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626 - No phaseTaking peopleFeasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
- Where
- Alicante, Barcelona, Murcia, Santa Cruz de Tenerife, Valencia
- Age
- 18 years and over
- People
- 140
- Run by
- Juan M Garcia-Gomez
See details and how to joinNCT07111195 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - Phase 1Taking peopleNeoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
- Where
- Madrid
- Age
- 18 years to 75 years
- People
- 12
- Run by
- Hospital San Carlos, Madrid
See details and how to joinNCT06418113